Compounds and compositions as TRK inhibitors
US9102671B2 · kind B2 · utility
58Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2012 |
| Grant date | Aug 11, 2015 |
| Priority date | — |
| Expiry date | May 17, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D207/09
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.